Rare primary fallopian tube carcinoma; a gynaecologist's dilemma

被引:2
|
作者
Chaudhry, Shama [1 ]
Hussain, Rubina [1 ]
Zuberi, Madiha Munir [2 ]
Zaidi, Zehra [2 ]
机构
[1] Ziauddin Univ Hosp, Dept Obstet & Gynaecol, Karachi, Pakistan
[2] Ziauddin Univ Hosp, Karachi, Pakistan
关键词
PFTC (Primary fallopian tube carcinoma); CA-125; levels; EOC (Epithelial ovarian cancer); BRCA-1 and BRCA-2 mutations;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary fallopian tube carcinoma is rare and accounts for 0.14-1.8% of all malignancies of the female genital tract. It has been found to be associated with nulliparity and subfertility, as well as with pelvic inflammatory disease. High parity has been reported to be protective but not in our 3 cases. History of pregnancy and the use of oral contraceptives decrease the PFTC risk significantly in literature. PFTC has been described in high-risk breast-ovarian cancer families with germ-line BRCA-1 and BRCA-2 mutations. Symptoms are nonspecific and include abdominal pelvic pain, vaginal bleeding and watery discharge. However, diagnosis is rarely achieved pre-operative because of misleading imaging. In many cases, the diagnosis is made incidentally on histopathology after surgery for an unrelated condition commonly being an ovarian carcinoma.
引用
收藏
页码:107 / 110
页数:4
相关论文
共 20 条
  • [1] Clinical and survival analysis of 36 cases of primary fallopian tube carcinoma
    Ying Ma
    Wei Duan
    World Journal of Surgical Oncology, 12
  • [2] Clinical and survival analysis of 36 cases of primary fallopian tube carcinoma
    Ma, Ying
    Duan, Wei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [3] Primary fallopian tube carcinoma in a 51-year-old postmenopausal woman - case report
    Vasiljevic, M.
    Pazin, V.
    Dzatic, O.
    Jeremic, D.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2007, 28 (06) : 531 - 533
  • [4] Preoperative diagnosis of the primary Fallopian tube carcinoma by three-dimensional static and power Doppler sonography
    Kurjak, A
    Kupesic, S
    Jacobs, I
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2000, 15 (03) : 246 - 251
  • [5] HE4 is associated with clinical risk prognostic factors and survival outcome in primary fallopian tube carcinoma patients
    Mi, Dong
    Zhang, Yuexiang
    Chen, Shuqin
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2022, 48 (07) : 1897 - 1903
  • [6] Gemcitabine in heavily pretreated patients with recurrent ovarian, peritoneal and fallopian tube carcinoma
    Piura, B
    Rabinovich, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2004, 25 (04) : 449 - 452
  • [7] Primary Chemotherapy for Inoperable Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without Delayed Debulking Surgery
    Saha, Antonio
    Varughese, Mohini
    Gallagher, Chris J.
    Orphanos, George
    Wilson, Peter
    Oram, David
    Jeyarajah, Arjun
    Reynolds, Karina
    Shepherd, John
    McCormack, Mary
    Olaitan, Adeola
    McDonald, Nicola
    Mould, Tim
    McNeish, Iain
    Ledermann, Jonathan A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (04) : 566 - 572
  • [8] Clinical usefulness of endometrial aspiration cytology and CA-125 in the detection of fallopian tube carcinoma
    Takeshima, N
    Hirai, Y
    Yamauchi, K
    Hasumi, K
    ACTA CYTOLOGICA, 1997, 41 (05) : 1445 - 1450
  • [9] Prognostic value of serum HE4 in patients with advanced ovarian, fallopian tube, and peritoneal carcinoma
    Dong Mi
    Yuexiang Zhang
    Archives of Gynecology and Obstetrics, 2020, 301 : 779 - 785
  • [10] Prognostic value of serum HE4 in patients with advanced ovarian, fallopian tube, and peritoneal carcinoma
    Mi, Dong
    Zhang, Yuexiang
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (03) : 779 - 785